OnePass Medical was founded in 2018 with a mission of saving lives by transforming biopsies both in terms of improving them (e.g., enabling to conduct them in one pass, thereby saving time and money) and in terms of upgrading them to include therapeutic capabilities (e.g., RF ablation and drug delivery). The company's vision is to develop additional applications that are not necessarily under the endoscope. OnePass Medical is supported by grants provided by the Israel Innovation Authority.